title: [Ten questions awaiting for a definitive answer on the use of non-vitamin K oral anticoagulants in atrial fibrillation].
abstract: After more than 3 years from the appearance in Italy of the non-vitamin K antagonist oral anticoagulants (NOACs), their use for the prevention of thromboembolism in atrial fibrillation is still limited, with wide differences in prescriptions across regions. When NOACs became available for clinical practice, several doubts arose about their practical management in the "real world". This article analyses the 10 more frequent questions asked by clinicians dealing with NOACs in their daily activity with atrial fibrillation patients. The answers are synthetic and schematic with pragmatic suggestions that could help clinicians in their doubts.
authors.affiliation: Divisione di Cardiologia, Ospedale Regionale San Maurizio, Bolzano.
authors.forename: Roberto
authors.initials: R
authors.lastname: Cemin
authors.affiliation: U.O Cardiologia, Ospedale Maggiore, Bologna.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Di Pasquale
authors.affiliation: Cardiologia Ospedaliera, Policlinico di Bari.
authors.forename: Paolo
authors.initials: P
authors.lastname: Colonna
authors.affiliation: Istituto di Cardiologia, Università degli Studi "G. d'Annunzio", Chieti-Pescara.
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caterina
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007558:Italy; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants